Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values
Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy of Euglycem in Reducing Blood Glucose in Patients With Dysglycemia After Three Months of Treatment - EUGLYCARE Study
Fondazione IRCCS Policlinico San Matteo di Pavia
108 participants
Apr 8, 2025
INTERVENTIONAL
Conditions
Summary
The primary objective is to evaluate the efficacy of Euglycem® plus recommended standard diet on reducing FPG compared to baseline and to recommended standard diet alone after 3 months
Eligibility
Inclusion Criteria3
- BMI ≤30 kg/m2
- subjects able to understand the informed consent and sign it before enrollment in the study
- subjects willing to follow all study requirements and perform all study visits as well as collaborate with the investigator.
Exclusion Criteria2
- ongoing treatment with drugs that can affect blood glucose
- current participation in another investigational drug or investigational device trial or inclusion in another investigational drug or investigational device trial within the previous month
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
An association of banaba leaves extract and chromium picolinate (Euglycem®) will be administered
Placebo
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07263789